ConnSante BioTech & Innovation, INC.
Update:2026/01/07
Industries
Main Industry
Health Care
Main Product/Service
ConnSante offers services such as the anti-cancer capability test, immune and tissue-repair system diagnostics, cancer prognosis and risk-assessment services, and tailored health-management and follow-up programs — particularly aimed at high-risk groups o
Founded Year
2025
Unified Business No.
60756906
Status
Active
Number of Employees
0
Total Paid-in
Capital
2,000,000 (NT$)
Location of Company
Taiwan
, Hsinchu City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
ConnSante Biotech is a molecular and cellular diagnostics company that, based on 25 years of research, developed a proprietary “anti-cancer capability test” designed to assess the health status of stem cells and immune cells — helping individuals evaluate